Bank of Montreal
TCRR

Bank of Montreal’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History

Bank of Montreal’s Portfolio TCRR Stock Details TCRR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,119
Closed -$25K – 5249
2021
Q1 		$25K Sell
1,119
-2,821
-72% -$76.9K ﹤0.01% 3975
2020
Q4 		$127K Buy
3,940
+2,763
+235% +$69.9K ﹤0.01% 3465
2020
Q3 		$24K Sell
1,177
-123
-9% -$2.16K ﹤0.01% 3769
2020
Q2 		$21K Buy
+1,300
New +$15K ﹤0.01% 3834
2020
Q1 		– Sell
-1,486
Closed -$21K – 4894
2019
Q4 		$21K Buy
1,486
+459
+45% +$7.1K ﹤0.01% 4302
2019
Q3 		$15K Buy
1,027
+874
+571% +$13.6K ﹤0.01% 4248
2019
Q2 		$2K Buy
+153
New +$2.44K ﹤0.01% 4775

Other funds holding TCRR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Bank of Montreal's TCRR Position: Q2 2021 in Review

Bank of Montreal sold out of TCR2 Therapeutics Inc. Common Stock (TCRR) in Q2 2021, closing a stake of 1,119 shares — an estimated $25K sold.

Bank of Montreal first reported a position in TCRR in Q2 2019 and held it in 7 quarters. The position peaked at $127K in Q4 2020. 119 funds tracked by Wall St. Rank hold TCRR as of Q2 2021.

  • Bank of Montreal reported no remaining TCR2 Therapeutics Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Bank of Montreal sold 1,119 TCR2 Therapeutics Inc. Common Stock shares in Q2 2021, an estimated $25K.
  • Bank of Montreal first reported a position in TCR2 Therapeutics Inc. Common Stock in Q2 2019 and held it in 7 quarters.
  • Bank of Montreal's TCR2 Therapeutics Inc. Common Stock position peaked at $127K in Q4 2020.
  • 119 funds tracked by Wall St. Rank held TCR2 Therapeutics Inc. Common Stock as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.